Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies. | Br J Haematol;2024 Jul 22. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Mitigating infection risks: The promise and challenge of bispecific antibodies in haematological malignancies.

Rafei, Hind; Rezvani, Katayoun.

Affiliation

Rafei H; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Rezvani K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Br J Haematol ; 2024 Jul 22.

Article in En | MEDLINE | ID: mdl-39039831

Key words

Tcells; bispecific antibodies; multiple myeloma; nonHodgkin lymphoma

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Country of publication: